These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32857484)

  • 1. White matter hyperintensities: a marker for apathy in Parkinson's disease without dementia?
    Zhang Y; Zhang GY; Zhang ZE; He AQ; Gan J; Liu Z
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1692-1701. PubMed ID: 32857484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH; Lee WJ; Chung SJ; Yoo HS; Jung JH; Baik K; Sohn YH; Seong JK; Lee PH
    J Parkinsons Dis; 2021; 11(1):239-249. PubMed ID: 33074193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
    Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Apathy and Depressive Symptoms Related to Vascular White Matter Hyperintensities in Severe Late Life Depression?
    Oudega ML; Siddiqui A; Wattjes MP; Barkhof F; Kate MT; Muller M; Bouckaert F; Vandenbulcke M; De Winter FL; Sienaert P; Stek ML; Comijs HC; Korten NCM; Emsell L; Eikelenboom P; Rhebergen D; van Exel E; Dols A
    J Geriatr Psychiatry Neurol; 2021 Jan; 34(1):21-28. PubMed ID: 32036772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients.
    Yu L; Yang L; Li Y; Yang S; Gu H; Hu W; Gao S
    Int J Neurosci; 2020 Mar; 130(3):231-236. PubMed ID: 31744348
    [No Abstract]   [Full Text] [Related]  

  • 8. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of white matter integrity correlates with apathy in Parkinson's disease.
    Zhang Y; Wu J; Wu W; Liu R; Pang L; Guan D; Xu Y
    Int J Neurosci; 2018 Jan; 128(1):25-31. PubMed ID: 28648111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics from magnetic resonance imaging may be used to predict the progression of white matter hyperintensities and identify associated risk factors.
    Shu Z; Xu Y; Shao Y; Pang P; Gong X
    Eur Radiol; 2020 Jun; 30(6):3046-3058. PubMed ID: 32086580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
    Morotti A; Shoamanesh A; Oliveira-Filho J; Schlunk F; Romero JM; Jessel M; Ayres A; Vashkevich A; Schwab K; Cassarly C; Martin RH; Greenberg SM; Qureshi AI; Rosand J; Goldstein JN;
    Neurocrit Care; 2020 Feb; 32(1):180-186. PubMed ID: 31218636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cross-sectional and longitudinal relationships between white matter hyperintensities and dementia in patients with Parkinson's disease: A retrospective analysis of 132 patients in a single center.
    Lee SJ; Lee DG
    Arch Gerontol Geriatr; 2016; 62():133-7. PubMed ID: 26541556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
    Sławek J; Roszmann A; Robowski P; Dubaniewicz M; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Kurzawski M; Bandurski T; Białecka M
    Neurodegener Dis; 2013; 12(1):1-12. PubMed ID: 22831964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study.
    Siciliano M; Trojano L; De Micco R; Giordano A; Russo A; Tedeschi G; Chiorri C; Tessitore A
    Parkinsonism Relat Disord; 2020 Oct; 79():3-8. PubMed ID: 32853825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
    Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF
    Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.